CTI BIOPHARMA CORP 4
4 · CTI BIOPHARMA CORP · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Plunkett Matthew
EVP, Corporate Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-03-01+60,000→ 60,000 totalExercise: $4.33Exp: 2027-02-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option is scheduled to vest in six semi-annual installments over the three-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.